Cellebrite DI Ltd.
CLBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $401,203 | $325,110 | $270,651 | $246,246 |
| % Growth | 23.4% | 20.1% | 9.9% | – |
| Cost of Goods Sold | $62,593 | $53,231 | $50,746 | $42,557 |
| Gross Profit | $338,610 | $271,879 | $219,905 | $203,689 |
| % Margin | 84.4% | 83.6% | 81.3% | 82.7% |
| R&D Expenses | $98,415 | $84,386 | $80,620 | $65,541 |
| G&A Expenses | $50,900 | $43,443 | $40,854 | $47,937 |
| SG&A Expenses | $183,289 | $154,256 | $138,241 | $124,326 |
| Sales & Mktg Exp. | $132,389 | $110,813 | $97,387 | $76,389 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $281,704 | $238,642 | $218,861 | $189,867 |
| Operating Income | $56,906 | $33,237 | $1,044 | $13,822 |
| % Margin | 14.2% | 10.2% | 0.4% | 5.6% |
| Other Income/Exp. Net | -$332,890 | -$108,800 | $119,716 | $68,483 |
| Pre-Tax Income | -$275,984 | -$75,563 | $120,760 | $82,305 |
| Tax Expense | $7,023 | $5,537 | -$45 | $10,909 |
| Net Income | -$283,007 | -$81,100 | $120,805 | $71,396 |
| % Margin | -70.5% | -24.9% | 44.6% | 29% |
| EPS | -1.35 | -0.43 | 0.64 | 0.5 |
| % Growth | -214% | -167.2% | 28% | – |
| EPS Diluted | -1.35 | -0.43 | 0.59 | 0.44 |
| Weighted Avg Shares Out | 209,472 | 190,155 | 182,693 | 144,002 |
| Weighted Avg Shares Out Dil | 209,472 | 190,155 | 195,394 | 161,539 |
| Supplemental Information | – | – | – | – |
| Interest Income | $18,219 | $8,888 | $2,025 | $847 |
| Interest Expense | $349,760 | $0 | $149 | $153 |
| Depreciation & Amortization | $10,607 | $10,011 | $9,194 | $7,007 |
| EBITDA | $67,513 | -$64,799 | $130,103 | $89,465 |
| % Margin | 16.8% | -19.9% | 48.1% | 36.3% |